Heinz-Werner Kleemann

This inventor holds 103 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 11 EPO patents, primarily in Pharmaceutical Chemistry (CPC class C07D-). Top assignees: Hoechst Aktiengesellschaft, Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma Deutschland, Gmbh. Active years: 1989-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heinz-Werner Kleemann. Retrieved from https://idiyas.com/inventor/heinz-werner-kleemann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 103 (Patent Applications = 2)

% Patents Active = 68.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 11 (Patent Applications = 2)

Average Co-Inventor Count = 3.9

ph-index = 14

Forward Citations = 687(Granted Patents)

Forward Citations (Not Self Cited) = 607(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Kelsterbach, DE (1989 - 1993)
Bishchofsheim, DE (2000)
Bad Homburg, DE (1995 - 2003)
Frankurt am Main, DE (2009)
Bischofsheim, DE (1996 - 2015)
Frankfurt-am-Main, DE (2011 - 2017)

Company Filing History:

48 out of 6,705

Hoechst Aktiengesellschaft

patents

23 out of 1,855

Sanofi-A Ventis Deutschland Gmbh

patents

20 out of 330

Aventis Pharma Deutschland, Gmbh

Hoechst Marion Roussel Deutschland Gmbh

patents

8. 1 out of 15

Hoeschst Aktiengesellschaft

patents

Years Active: 1989-2017

Loading Chart...

Areas of Expertise:

Pharmaceuticals

Isoquinoline Derivatives

Rho Kinase Inhibitors

Sulfonamides

Acylamino Substitutes

Carboxylic Acids

Benzoylguanidines

Pentafluorosulfanyl

Diagnostic Aids

Intermediates

Guanidinocarbonyl

Anthranilamides

103 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9718825 - N-(4-(azaindazol-6-yl)-phenyl)-sulfonamides and their use as pharmaceuticals (2017-08-01),

2. 9018383 - Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals (2015-04-28),

3. 8618304 - Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals (2013-12-31),

4. 8541449 - Substituted isoquinolines and isoquinolinones as Rho kinase inhibitors (2013-09-24),

5. 8455469 - Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels (2013-06-04),

6. 8404893 - Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them (2013-03-26),

7. 8399482 - 6-substituted isoquinolines and isoquinolinones (2013-03-19),

8. 8304438 - Heteroarylacrylamides and their use as pharmaceuticals (2012-11-06),

9. 8283374 - Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives (2012-10-09),

10. 8188291 - Heteroaryl-substituted carboxamides and their use as pharmaceuticals (2012-05-29),

11. 8076324 - Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them (2011-12-13),

12. 8008352 - Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them (2011-08-30),

13. 7932416 - Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates (2011-04-26),

14. 7772262 - Substituted benzoylguanidines, method for production and use thereof as medicament or diagnostic and medicament comprising the same (2010-08-10),

15. 7763661 - Ortho-substituted pentafluorosulfanyl benzenes, method for the production thereof and their use as synthesis intermediates (2010-07-27),

Title: Heinz-Werner Kleemann: Pioneering Inventor from Bischofsheim

Introduction: Heinz-Werner Kleemann is a distinguished inventor hailing from Bischofsheim, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kleemann holds several patents in various technological domains, including advancements in renewable energy systems, smart home devices, and medical equipment.

Career Highlights: With a career spanning over three decades, Kleemann has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries worldwide.

Collaborations: Throughout his career, Kleemann has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life, resulting in successful products that have garnered international acclaim.

Conclusion: Heinz-Werner Kleemann's relentless passion for innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.